Theradaptive, a Frederick-based biotechnology company specializing in therapeutic delivery platforms, Wednesday announced a $4 million Technology & Therapeutic Development Award (TTDA)…
MARYLAND - February 22 2023 – Today, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announces a Technology…
CHARLOTTESVILLE, Va., February 28, 2023 -- AMPEL BioSolutions today announced a genomic precision medicine test for chronic kidney diseases, such as Lupus Nephritis,…